7:15 AM ET
8-K
Leadership Change
Enanta Pharmaceuticals Leadership Change
Jay R. Luly, Ph.D., has announced his intention to retire as President and CEO of Enanta Pharmaceuticals by February 1, 2027, after 23 years of leadership. Simultaneously, the company appointed Tara L. Kieffer, Ph.D., to the newly created role of Chief Operating Officer to drive operational execution and strategic alignment.